148/Pn/2026 - Delivery of the Medicinal Product Treprostinil Tender

• Country: Poland
• Summary: 148/Pn/2026 - Delivery of the Medicinal Product Treprostinil for Uck
• PLT Ref No: 140852502
• Deadline: 22 May 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 313155-2026
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Part 1 1. The subject of the order is the supply of the medicinal product Treprostinil for UCK in the assortment, estimated quantity and requirements specified in Annex 3 to the SWZ. 2. The Ordering Party does not allow the submission of partial offers. Subject of the order there is one medicinal product. 3. As part of the items marked in the assortment and price form with the symbol (**) in Annex No. 3 to the SWZ, the Ordering Party requires that the offered preparation be included in the catalog of reimbursed medicines used in programs drugs. 4. Deliveries will be made successively, in quantity and assortment, in accordance with the Ordering Party's partial orders, within 2 days from the date of placing the order, and "cito" delivery within 12 hours from placing the order. Ordered assortment The Contractor will be obliged to deliver it to the Hospital Pharmacy at his own expense. 5. The Ordering Party requires that the prices of the offered medicines are no higher than the official prices specified in Art. 9 section 1 and 2 of the Act of May 12, 2011 on the reimbursement of medicines and foodstuffs special nutritional uses and medical devices (Journal of Laws of 2024, item 930), valid on the date of submission of offers. 6. The offered medicinal products must comply with the Act of September 6, 2001, Pharmaceutical Law (Journal of Laws of 2024, item 696) - if applicable. The offered medicinal products must be admitted to trading in Poland in accordance with the principles set out in Art. 3 or 4a of the Pharmaceutical Law. 7. If the Ordering Party used...
• Documents:

 Tender Notice